SCHEMBL17050816

SCHEMBL17050816

Cc1ccc(Oc2ccc(Br)cn2)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 6/20 0.42
MAPT P10636 5/20 0.42
RAB9A P51151 3/20 0.42
ATM Q13315 1/20 0.42
HPGD P15428 4/20 0.42
KMT2A Q03164 3/20 0.42
POLB P06746 3/20 0.42
MEN1 O00255 2/20 0.42
MAPK1 P28482 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
ALDH1A1 P00352 2/20 0.42
USP2 O75604 1/20 0.42
ALOX12 P18054 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HTT P42858 2/20 0.39
TP53 P04637 1/20 0.39
NPC1 O15118 2/20 0.39
KDM4E B2RXH2 3/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30454767 0.86 ACHE (0.50) L3MBTL1MAPTRAB9AHPGDKMT2A
SCHEMBL25355273 0.86 ACHE (0.50) L3MBTL1MAPTRAB9AHPGDKMT2A
SCHEMBL25353410 0.84 TRPA1 (0.37) L3MBTL1MAPTRAB9AKMT2APOLB
SCHEMBL17050452 0.84 MAPK8 (0.43) L3MBTL1RAB9AHPGDKMT2APOLB
SCHEMBL17050467 0.83 KDM4E (0.43) L3MBTL1MAPTRAB9AKMT2APOLB
SCHEMBL17050451 0.83 L3MBTL1 (0.41) L3MBTL1MAPTHPGDKMT2APOLB
SCHEMBL25355051 0.83 ALOX15 (0.39) MAPTRAB9AHPGDKMT2APOLB
SCHEMBL17050453 0.81 ACACB (0.53) L3MBTL1MAPTRAB9AATMHPGD
SCHEMBL25355182 0.81 PDE4A (0.39) L3MBTL1MAPTRAB9AHPGDKMT2A
SCHEMBL30454375 0.81 GAA (0.38) L3MBTL1MAPTRAB9AHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150246938-A1 NOVEL OLEFIN DERIVATIVE SHIONOGI & CO., LTD. (JP) 2015-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150246938-A1 NOVEL OLEFIN DERIVATIVE ACSS2, ACACB, ACAT2 L3MBTL1 3849/4885MAPT 3309/4885RAB9A 3407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.